Normal
9th - 10th March 2023

MarketsandMarkets Next-Gen Genomics and Proteomics Conference

ILEC Conference Centre & Ibis London Earls Court, London

Neoteric Breakthrough in Scientific and Clinical Paradigms of Genomics and Proteomics

Leading our way back to the ambitious research collaboration, Human Genome Project has paved ways in transforming biology and biological discovery. As a result of which, the fundamentals of Genomics and Proteomics have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. The swift growth in high throughput technologies used for genomic and proteomic profiling has factored breakthroughs for a much-anticipated personalized medicine approach for complex diseases.

MarketsandMarkets is delighted to announce its Next-Gen Genomics and Proteomics Conference scheduled to be held on 9th - 10th March 2023 in London,UK. The conference will assimilate diverse sessions on Functional genomics and Organellar Proteomics in Biomedicine, Applied and Translational genomics, Epigenomics in Systems Biology, Immune Phenotyping – Flowcytometry and Immuno Metabolic Markers- Polygenic Risk Scores, Next Generation Sequencing and Single Cell Sequencing for Disease Diagnosis, Electrospray Mass Spectrometry-based Biomarkers, Multidimensional Liquid Chromatography in Clinical Proteomics, Genome Wide Variant Data and Application of Omics in Protein – Protein Interaction. The event encompasses networking sessions, panel discussions, solutions, and services catering to Genomics and Proteomics research. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in the field of multi-Omics research.

Co-Located Conferences
WHAT TO EXPECT

Key highlights

  • Systemic Implementation of Functional Genomics, Organellar Proteomics for Biomedicine
  • Protein – DNA interaction Molecular and Cellular Mechanism, Applied and Translational Genomics in Systems Biology
  • Gene Expression and Molecular Mechanism in Immune Signaling, Flow Cytometry in Immune Phenotyping, Polygenic Risk Scores for Immuno Metabolic Markers
  • Predisposition of Biomarkers - NGS-RNA Sequencing, Single Cell Sequencing using Circulating Tumor Cells in Disease Diagnosis
  • Electrospray Mass Spectrometry based Biomarkers, Development of Multidimensional Liquid Chromatography, Spatial Profiling in Tumor Proteomics
  • Advances in Genome Wide Variant Data and Application of Omics in Protein – Protein interaction

Why attend?

  • Witness live action how Genomics and Proteomics is revolutionizing the future of Biomedical research
  • Quality insights and cohesiveness of key issues with respect to Genomics and Proteomics to be addressed
  • Discover the different avenues in application of Omics studies
  • Comprehend the current and future research avenues in drug discovery using Genomics and Proteomics
  • Discuss the emerging technologies and opportunities with cutting edge strategies
  • Opportunity for one-on-one networking with the delegates and extend professional competency

Who should attend?

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science

CONFERENCE AGENDA
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Advisors
Manuel Corpas
Manuel Corpas
Scientific Director, Cambridge Precision Medicine
Mark Stern
Mark Stern
Senior Director, Head Clinical Genetics and Genomics, Bristol Myers Squibb
Kenneth Linton
Kenneth Linton
Professor of Protein Biochemistry, Queen Mary University of London
Ricardo Carreira
Ricardo Carreira
Associate Director - Proteomics, Immunocore
Speakers
Saumyaa Saumyaa
Saumyaa Saumyaa
Senior Research Scientist, AstraZeneca
Eleanor Wheeler
Eleanor Wheeler
Associate Principal Scientist, Genome Analytics, AstraZeneca
Manuel Corpas
Manuel Corpas
Scientific Director, Cambridge Precision Medicine
Ricardo Carreira
Ricardo Carreira
Associate Director - Proteomics, Immunocore
Please contact [email protected] for speaking opportunity
SPONSORS
Silver
example-image

Bionano Genomics

Exhibition Partner
example-image

Biognosys

example-image

Agilent

example-image

Quantabio

LOCATION
ILEC Conference Centre & Ibis London Earls Court, London
About the Hotel

PAST EVENT GALLERY